Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol Mouthwash for Halitosis and Gingivitis
NCT06882564Phase 3Recruiting
- Sponsor
- Al-Mustansiriyah University
- Start
- Jan 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of resveratrol in halitosis and gingivitis (3 arms), sponsored by Al-Mustansiriyah University. Primary endpoints: Change in oral halitosis (oral malodor) at Day 7, Change in clinical periodontal parameters (gingival index) at Day 7 and 3 more. Started Jan 2025; status: recruiting.
02
Drugs
resveratrol
03
Conditions
halitosisgingivitis
Beyond the preview
Go deeper on NCT06882564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06882564.